Ms. KM Chanda Hemaliya is an emerging biomedical and molecular research scholar with specialized expertise in molecular genetics, hematology, hemophilia research, and clinical laboratory sciences. She qualified the prestigious CSIR-UGC NET-JRF in 2020 with an All India Rank of 170, demonstrating strong academic and research aptitude.

Her research activities are particularly focused on the molecular characterization of Factor VIII gene variants, hemophilia A carrier detection, genetic polymorphisms, genotype–phenotype relationships, and clinical profiles of inherited bleeding disorders.

Research & Scientific Contributions

Ms. Hemaliya has developed an expanding publication portfolio covering hemophilia A and B, Factor VIII gene genetics, carrier screening, inhibitor status, therapeutic strategies, hematological disorders, diabetes, and metabolic health. Her research includes studies involving large patient cohorts and genetic-marker analysis, contributing to improved understanding of the molecular and clinical landscape of hemophilia in Indian populations.

Her notable publications include research on Factor VIII gene variants and genotype-haplotype relationships, genetic landscapes and linkage analysis of Factor VIII markers in Indian women, and clinical, inhibitor, and intragenic polymorphism profiles in hemophilia A.

International & National Scientific Presentations

Ms. Hemaliya has actively presented her research at major scientific forums, including Hemocon Kashi 2024 and 2025. Her research was also presented at the International Society of Hematology (ISH) 2026 in Bangkok, Thailand, on the clinical spectrum, inhibitor profile, and intragenic F8 polymorphism distribution among 345 hemophilia A patients in Eastern India.

These presentations demonstrate her ability to communicate clinically relevant molecular and hematological research to national and international scientific audiences.

Technical & Research Expertise

Her technical expertise encompasses a broad range of molecular and clinical laboratory methodologies, including:

• DNA/RNA extraction and molecular assay development
• Conventional PCR and Real-Time PCR
• ARMS-PCR and Inverse Shifting PCR
• HLA typing and ELISA
• Sanger sequencing and mutation analysis
• Genetic and carrier screening
• Agarose gel electrophoresis and restriction enzyme digestion
• Bacterial culture and microbial identification
• Clinical sample processing and laboratory quality control
• Statistical analysis using SPSS and GraphPad Prism

This combination of molecular biology and clinical laboratory expertise supports her translational research in inherited hematological disorders.

Book Chapters & Academic Contributions

Ms. Hemaliya has contributed to the book “Hemophilia Guidelines and Management”, published by the Hemophilia Federation (India) in 2025. Her contributions include chapters on Diagnosis of Haemophilia and Management of Haemophilia and Inhibitors, demonstrating her engagement beyond journal publications and her contribution to academic and clinical knowledge dissemination.

Training & Professional Development

She has undertaken specialized workshops and training programmes in platelet signaling and thrombus biology, karyotyping, QF-PCR, cytogenetic analysis, molecular genetics, and intellectual property rights. Her participation in the 2026 Hemostasis 360°: Understanding Hemophilia – Fundamentals & Interdisciplinary Approach programme further strengthened her exposure to contemporary multidisciplinary approaches in hemophilia care and research.

Research Focus

Her principal research interests include:

• Molecular genetics of hemophilia
• Factor VIII gene mutations and polymorphisms
• Hemophilia A carrier identification
• Genotype–phenotype correlation
• Inhibitor development in hemophilia
• Genetic counselling and carrier screening
• Molecular diagnostics
• Inherited bleeding disorders
• Gene-based and targeted therapeutic approaches
• Translational hematology and clinical genomics

Academic & Research Potential

Ms. KM Chanda Hemaliya demonstrates a promising combination of academic excellence, molecular research expertise, clinical research exposure, scientific publications, international conference participation, and specialized training. Her research on hemophilia genetics has particular relevance to improving molecular diagnosis and carrier detection, especially among Indian populations.

Eligibility for Young Researcher Award 

Ms. KM Chanda Hemaliya is eligible for the Young Researcher Award in Scientific Laurels. Her candidature is supported by her CSIR-UGC NET-JRF qualification with an All India Rank of 170, growing portfolio of peer-reviewed publications, international and national scientific presentations, research focused on Factor VIII genetics and hemophilia, contributions to hemophilia-management guidelines, and advanced technical expertise in molecular diagnostics and genetic analysis.

Her presentation at ISH 2026 in Bangkok, research involving a cohort of 345 hemophilia A patients, and continued contributions to molecular hematology demonstrate strong early-career research potential. Her interdisciplinary approach connecting molecular genetics, clinical hematology, laboratory diagnostics, and translational medicine makes her a strong candidate for recognition as a Young Researcher in Scientific Laurels.